Status:
RECRUITING
Continuous Glucose Monitoring in Infants
Lead Sponsor:
University of California, San Diego
Collaborating Sponsors:
DexCom, Inc.
Conditions:
Neonatal Hypoglycemia
Eligibility:
All Genders
1-2 years
Brief Summary
The purpose of this study is to employ continuous glucose monitoring to measure glucose profiles in newborn infants.
Detailed Description
We will place a continuous glucose monitor on the infant within 2 hours of birth and record blood glucose values every 5 minutes via the monitor; in addition, the infant will receive blood glucose che...
Eligibility Criteria
Inclusion
- Mother at least 18 years of age
- Infants born either appropriate for gestational age (AGA) or large for gestational age (LGA)
- Skin fold over superior gluteus area at least 1 inch in thickness as measured by skin calipers
Exclusion
- Infants born small for gestational age (SGA)
- Infant birth weight \<2.5 kg
- Infant BMI \<10th percentile on Olsen chart
- Infants born \<38 weeks gestation
- Infants with concern for intrauterine growth restriction (IUGR) and short femur length based on ultrasound
- Mother is non-English speaking
Key Trial Info
Start Date :
October 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04458649
Start Date
October 1 2020
End Date
December 31 2024
Last Update
July 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSD Medical Center
La Jolla, California, United States, 92037